Abstract Details

Title A Double-Blind, Randomized, Parallel Group Design Comparison of Botulinum Toxin, Type A (Botox[reg]) and Botulinum Toxin, Type B (Myobloc[trade]) on Autonomic Symptoms and Physiology in Patients with Cervical Dystonia

Topic

Presentation(s)

Poster/Presentation
Number 003

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Dwain Tolbert, PhD (Lundbeck LLC)	No disclosure on file
	No disclosure on file
Achint A. Patel (Icahn School of Medicine At Mount Sinai)	No disclosure on file
	No disclosure on file
Hiroyuki Murai, MD (International University of Health and Welfare)	Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chugai Pharmaceutical. The institution of Dr. Murai has received research support from Japan Blood Products Organization.